Whether manufacturer Philip Morris International (PMI) will be permitted to claim IQOSs status as a modified risk tobacco product (MRTP) is still being reviewed by the FDA
Brittney Keller-Hamilton, an epidemiologist with the Center for Tobacco Research at Ohio State Universitys Comprehensive Cancer Center, said Philip Morris has shared no evidence of how the proposed marketing statement would affect teenagers
Ideally, wed have plain packaging policies for all tobacco products, which are known to reduce use, but for now, we are pushing for larger warnings on cigarette packs
Chances are, theyve got quite a story to tell.
Common side effects include nasal irritation, runny nose, watery eyes, throat irritation, and coughing.Nicotine Lozenges Nicotine lozenges are small tablets that dissolve slowly in the mouth, gradually releasing nicotine